| Epicardial ablation of ventricular tachycardia: An institutional experience of safety and efficacy. | |
| | |
MedLine Citation:
|
PMID: 23246598 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Epicardial ablation has been shown to be a useful adjunct for treatment of ventricular tachycardia (VT). OBJECTIVE: To report the trends, safety and efficacy of epicardial mapping and ablation at a single center over an eight-year period. METHODS: Patients referred for VT ablation (6/2004-6/2011) were divided into three groups: ischemic cardiomyopathy (ICM), nonischemic cardiomyopathy (NICM), and idiopathic ventricular arrhythmias (VA). Scar-mediated VT patients that underwent combined epicardial and endocardial (epi-endo) mapping and ablation were compared with those that underwent endocardial ablation only (endo-only) with regards to patient characteristics, acute procedural success, 6 month and 12 month clinical outcomes. RESULTS: Amongst 144 patients referred for VT ablation, 95 patients underwent 109 epicardial procedures (94% access rate). Major complications were seen in 8 patients (8.8%) with pericardial bleeding (>80cc) in 6 cases (6.7%), although no tamponade, surgical intervention, or procedural mortality was seen. Patients with ICM who underwent a combined epi-endo ablation had improved freedom from VT compared to those with endo-only ablation at 12 months (85% vs 56%, p=0.03). In NICM patients, no differences were seen between those that underwent epi-endo ablation compared to those with endo-only ablation at 12 months (36% vs 33%, p=1.0). In idiopathic VA, only 2/17 patients were successfully ablated from the epicardium. CONCLUSIONS: In this large tertiary single-center experience, complication rates are acceptably low and improved clinical outcomes were associated with epi-endo ablation in ICM patients. NICM patients represent a growing referred population, although clinical recurrence remains high despite epicardial ablation. Epicardial ablation has a low yield in idiopathic VA. |
| | |
Authors:
|
Roderick Tung; Yoav Michowitz; Ricky Yu; Nilesh Mathuria; Marmar Vaseghi; Eric Buch; Jason Bradfield; Osamu Fujimura; Jean Gima; William Discepolo; Ravi Mandapati; Noel Boyle; Kalyanam Shivkumar |
Related Documents
:
|
6437508 - Long term follow up of untreated primary hyperparathyroidism. 15235928 - A randomized open-label comparative study of conventional therapy versus mizoribine onl... 18379238 - Impact of minimal increases in serum creatinine on outcome in patients after cardiothor... 10213638 - Supportive treatment improves survival in multivisceral cholesterol crystal embolism. 20074858 - Treatment of horses with cypermethrin against the biting flies culicoides nubeculosus, ... 11215838 - Anticoagulation therapy for radiation-induced myelopathy. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-12-11 |
Journal Detail:
|
Title: Heart rhythm : the official journal of the Heart Rhythm Society Volume: - ISSN: 1556-3871 ISO Abbreviation: Heart Rhythm Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2012-12-18 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101200317 Medline TA: Heart Rhythm Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012. Published by Elsevier Inc. |
Affiliation:
|
UCLA Cardiac Arrhythmia Center, UCLA Health System, David Geffen School of Medicine at UCLA, Los Angeles, CA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sympathetic Nerve Fibers and Ganglia inCanine Cervical Vagus Nerves: Localization and Quantitation.
Next Document: Inhibition of CaMKII Phosphorylation of RyR2 Prevents Inducible Ventricular Arrhythmiasin Mice with ...